The Prostate Cancer Foundation has announced grants totaling $3.5 million to four teams of investigators conducting innovative research on treatments and a cure for prostate cancer.
Funded primarily by the Movember Foundation, the 2018 Movember Foundation-PCF Challenge Awards will support cross-disciplinary teams of at least three investigators, one of whom must be a young investigator.
Investigators receiving $1 million awards include Mark Pomerantz, Harvard: Dana-Farber Cancer Institute, and Philip Kantoff, Memorial Sloan Kettering Cancer Center ("The Impact of DNA Damage Repair Abnormalities in Prostate Cancer"); Julie Graff, VA Portland Health Care System, Amy Moran, Oregon Health & Science University, and Karen Sfanos, Johns Hopkins University ("Fecal Microbiota Transplant to Enhance Response to PD-1 Inhibition in Metastatic Castration Resistant Prostate Cancer"); and the Duke University team of Steven Patierno, Daniel George, Jennifer Freedman, Jiaoti Huang, Amanda Hargrove, and Muthana Al Abo ("Targeting RNA Splicing in Race-Related Aggressive and Lethal Prostate Cancer"). A $500,000 grant also was awarded to the team of Susan Halabi, (Duke University), Christopher Sweeney, (Harvard: Dana-Farber Cancer Institute), and Jayne Tierney (University College London) ("Surrogate Endpoints of Overall Survival in Men with Metastatic Hormone Sensitive Prostate Cancer").
"The Prostate Cancer Foundation values its ongoing relationship with the Movember Foundation and is greatly appreciative of their generous donation," said PCF president and CEO Jonathan W. Simons. "This year's selection of Challenge Award recipients builds on our longstanding commitment of supporting innovative research that we hope will lead to life-saving therapies for men diagnosed with prostate cancer."
(Photo credit: gettyimages)